Open AccessEuglycemic DKA (euDKA) as a presentation of COVID‐19
Author(s) -
Dass Bhagwan,
Beck Andrew,
Holmes Cody,
Morton Glenville
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3540
Subject(s) - medicine , discontinuation , covid-19 , presentation (obstetrics) , intensive care medicine , pediatrics , virology , surgery , disease , outbreak , infectious disease (medical specialty)
COVID‐19 in the setting of SGLT2 inhibitor use may precipitate euglycemic DKA separate from known acute viral illness and dehydration precipitants. There should be consideration of proactive discontinuation of these medications in these patients.